Price: $40.79, Change: $-2.55, Percent Change: -5.87%
Related Articles
Adaptive Biotechnologies Weighs Separation of Immune Medicine Unit; Shares Fall After Hours
Adaptive Biotechnologies (ADPT) is evaluating strategic and structural alternatives for its immune medicine segment in a plan to separate the business from its minimal residual disease division.A decision on the separation is expected by year-end, the company said Monday in a statement.Adaptive shares fell 5.6% in after-hours trading.
High Tide Swings to Fiscal Q2 Profit, Revenue Rises; Shares Gain After Hours
High Tide (HITI) reported fiscal Q2 adjusted earnings late Monday of 0.01 Canadian dollars per diluted share, compared with the loss of C$0.04 a year earlier.Three analysts surveyed by FactSet expected a loss of C$0.02.Revenue in the three months ended April 30 rose to C$179.3 million from C$137.8 million a year ago.Analysts surveyed by FactSet expected C$171.2 million.High Tide shares rose 15% in after-hours trading.
Dave & Buster's Entertainment Fiscal Q1 Adjusted Earnings, Revenue Decline
Dave & Buster's Entertainment (PLAY) reported fiscal Q1 non-GAAP net income late Monday of $0.22 per diluted share, down from $0.76 a year earlier.Analysts polled by FactSet expected $0.56.Revenue for the quarter ended May 5 was $559.2 million, down from $567.7 million a year earlier.Analysts expected $580.6 million.Shares of the company were down about 4% in after-hours trading.